ArticleCells2020

DNA Damage- But Not Enzalutamide-Induced Senescence in Prostate Cancer Promotes Senolytic Bcl-xL Inhibitor Sensitivity.

Nicolas Malaquin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.